Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

Research Exchanges

Showing 11 - 20 of 58 posts
Oct 24, 2013

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching...

Oct 17, 2013

Dr. Kevin Lustig talks about strategic outsourcing and bringing pharma and drug discovery into the information age in an article he recently wrote...

Oct 15, 2013

Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and...

Oct 8, 2013

This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered...

Oct 1, 2013

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

Sep 26, 2013

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research...

Sep 10, 2013

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Aug 13, 2013

Scientist announced this morning, the launch of MXIS (Market Exchange for Innovative Services), a virtual outsourcing platform for Pfizer...

Aug 6, 2013

Cloud-based Platform Brings Together Life Science Researchers Worldwide; Fuels Innovation at NCI “The mission of CCR is to conduct...

Jul 29, 2013

At Scientist, we feel strongly about promoting Open Science and have sponsored a fantastic show on Mendelspod today: an interview with Dr Ethan...